Charles N York II insider trades

Open-market stock purchases and sales by Charles N York II, COO and CFO at Day One Biopharmaceuticals, Inc, from SEC Form 4 filings since Apr 12, 2016.

Recent trades

DateStockTradeValue
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)$4.5M
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)$1.4M
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)$1M
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)$1.5M
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)$2.1M
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Apr 23, 2026DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Feb 17, 2026DAWN Day One Biopharmaceuticals, IncSold$70.4K
Feb 15, 2026DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Feb 15, 2026DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Feb 15, 2026DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Jan 30, 2026DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Jan 30, 2026DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Nov 17, 2025DAWN Day One Biopharmaceuticals, IncSold$36.2K
Nov 15, 2025DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Nov 15, 2025DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Nov 15, 2025DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Nov 6, 2025DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Nov 6, 2025DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Nov 6, 2025DAWN Day One Biopharmaceuticals, IncSold (not open market)—
Nov 6, 2025DAWN Day One Biopharmaceuticals, IncBought (not open market)—
Nov 6, 2025DAWN Day One Biopharmaceuticals, IncSold (not open market)—

Companies traded

  • DAWN Day One Biopharmaceuticals, Inc: 32 sales, last Apr 23, 2026
  • AGLE Aeglea BioTherapeutics, Inc: 6 buys, last Feb 14, 2020

Get free alerts when Charles N York II files a new trade →